• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

UBS

New COVID-19 variants could diminish vaccine efficacy

January 20, 2021 By Brian Buntz

COVID-19 is mutating. And while early data suggest vaccines will be effective against more infectious COVID-19 variants that emerged in the U.K., South Africa and Brazil, the mutations could have a measurable impact on vaccine efficacy.   There’s perhaps a 50/50 chance that such new variants could lead to a “numerically meaningful drop” in vaccine efficacy, […]

Filed Under: Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Moderna, Pfizer, Shane Crotty, UBS

Boston Sci among UBS analysts’ top stock picks for 2021

December 17, 2020 By Sean Whooley

UBS Investment Bank listed Boston Scientific (NYSE:BSX) among its 21 most compelling stock investment selections for 2021. Marlborough, Mass.-based Boston Scientific was the only medical device company on a list that featured companies such as Amazon, Morgan Stanley and Southwest Airlines. Additionally, Vertex Pharmaceuticals represented the biotech space, while Acadia Healthcare registered for healthcare facilities. UBS […]

Filed Under: Business/Financial News, Cardiovascular, Featured, MassDevice Earnings Roundup, Replacement Heart Valves, Structural Heart, Wall Street Beat Tagged With: Boston Scientific, tavr, UBS

Who would — and wouldn’t — line up for COVID-19 vaccines?

November 24, 2020 By Nancy Crotti

Once enough people receive effective vaccines against the novel coronavirus, experts say, the end of the pandemic may be in sight. But a new poll of older adults — one of the highest-priority groups for vaccination — suggests an uphill climb lies ahead to reach that goal. In all, 58% of adults aged 50 to […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceutical, Research & Development Tagged With: AARP, BioNTech, coronavirus, COVID-19, Moderna, Pfizer, U.S. Centers for Disease Control and Prevention, UBS, University of Michigan, vaccines

The new COVID-19 wave could be bad news for the medical device industry

November 17, 2020 By Chris Newmarker

Surging COVID-19 cases across the U.S. could hold medical procedures back for the rest of the year, according to a new report from UBS analysts. If the UBS analysts’ prediction proves accurate, medical device companies could face a challenging environment for the rest of the year, even as they provide the technology, tests and supplies […]

Filed Under: Business/Financial News, Featured Tagged With: coronavirus, COVID-19, UBS

How much is COVID-19 affecting procedure volumes for medtech?

October 22, 2020 By Sean Whooley

UBS Financial Services released a report detailing how it expects medtech procedures to potentially keep dipping during the COVID-19 pandemic. The report highlighted a quicker-than-expected recovery in the second quarter after U.S. hospitals began canceling, delaying and deferring elective procedures in late March as the pandemic took hold. However, UBS still expects third-quarter medical procedures […]

Filed Under: Business/Financial News, Featured, Surgical Tagged With: Baxter, becton dickinson, Boston Scientific, coronavirus, COVID-19, Dexcom, Insulet, Masimo, Medtronic, Senseonics, Stryker, UBS, Zimmer Biomet

Dynatronics promotes COO Baker to replace von Jako as CEO | Personnel Moves, August 30, 2019

August 30, 2019 By Brad Perriello

After deciding this week that its CEO needs to be based in Eagan, Minn., and with chief executive Chris von Jako unwilling to relocate his family, Dynatronics (NSDQ:DYNT) promoted COO Brian Baker to the corner office, effective August 28. “After thoughtful consideration, the board of directors determined that the company’s CEO needs to be based in […]

Filed Under: Business/Financial News, Featured Tagged With: ATL Technology, Cook Medical, Dynatronics Corp, Echosens, Fresenius, Harmonic Bionics, Iradimed Corp, Orchestra BioMed, Penumbra Inc., Personnel Moves, UBS

Texas doc nearly clear of over-stenting charges | Legal News

November 28, 2011 By MassDevice staff Leave a Comment

Dr. Samuel DeMaio

Dr. Samuel DeMaio

A Texas doctor accused of unnecessary stenting has slipped three of four trials against him with his license to practice in the Lone Star State intact.

Dr. Samuel DeMaio, accused last year of standard-of-care violations related to nine patients who allegedly received un-needed stents, angiograms and ICD implants, had pushed for a trial after mediation efforts with the Texas Medical Board collapsed.

Filed Under: Legal News, News Well, Patent Infringement, Stents Tagged With: ArthroCare Corp., InSite Vision Inc., Legal Roundup, MediCor, Securities & Exchange Commission (SEC), Silver Oak Capital LLC, UBS

Abiomed, Thoratec and Heartware listed as potential buyout candidates by UBS

June 27, 2011 By MassDevice staff Leave a Comment

ABMD logo
Thoratec
HeartWare

Abiomed Inc.’s (NSDQ:ABMD recent good fortune may make it a prime acquisition target, according to Wall Street analysts.

Filed Under: Business/Financial News, News Well, Wall Street Beat Tagged With: Abiomed, HeartWare International Inc., Thoratec Corp., UBS

BSX outlook gets mixed reviews from Wall Street

June 24, 2011 By MassDevice staff Leave a Comment

BSX

Boston Scientific Corp. (NYSE:BSX) garnered two upgrades and one downgrade from analysts this week, creating a roller-coaster effect in stock prices for the medical device giant.

The company’s stock has been closing at higher and higher values all week, but slid nearly 4 percent in midday trading Friday after an analyst at wealth management service UBS downgraded the stock from buy to neutral.

Wall Street analyst Rajeev Jashnani said the stock isn’t likely to trade higher until BSX can report sustained revenue.

Filed Under: Business/Financial News, News Well, Wall Street Beat Tagged With: Boston Scientific, Moody's Investor Service, Stifel Nicolaus, UBS

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS